- Docket No.
- 24-1821
- Appellate Court
- Third Circuit
Goal
- Block government from enforcing results of negotiation
- Declaration that provisions are unconstitutional
Issues
Case History
Litigation Content
Why this Matters:
The plaintiff argues that the Inflation Reduction Act’s Medicare drug negotiation process violates the First Amendment, the Takings Clause of the Fifth Amendment, and creates an unconstitutional condition on Medicare and Medicaid participation. Medicare’s authority to negotiate the price of certain single-source, high-priced drugs is estimated to result in substantial savings for Medicare beneficiaries and the federal government.
Potential Impact:
Successful challenges to Medicare’s negotiation authority would negate savings to Medicare beneficiaries and taxpayers, and could severely restrict federal regulatory authority in the health care arena.
21 Major Filings
- AMICUS BRIEF (Biotechnology Innovation Organization) (Jul 19, 2024)
- AMICUS BRIEF (Independent Women's Forum) (Jul 19, 2024)
- AMICUS BRIEF (New Civil Liberties Alliance) (Jul 19, 2024)
- AMICUS BRIEF (National Taxpayers Union Foundation) (Jul 19, 2024)
- AMICUS BRIEF (Daniel E. Troy) (Jul 19, 2024)
- AMICUS BRIEF (National Association of Manufacturers) (Jul 19, 2024)
- AMICUS BRIEF (Pioneer Public Interest Law Center) (Jul 19, 2024)
- AMICUS BRIEF (Chamber of Commerce) (Jul 19, 2024)
- AMICUS BRIEF (Institute for Free Speech) (Jul 19, 2024)
- AMICUS BRIEF (Buckeye Institute) (Jul 19, 2024)
- AMICUS BRIEF (Manhattan Institute) (Jul 19, 2024)
- AMICUS BRIEF (Alliance for Aging Research) (Jul 19, 2024)
- AMICUS BRIEF (Fresenius Kabi) (Jul 19, 2024)
- AMICUS BRIEF (Teva Pharmaceuticals USA Inc.) (Jul 19, 2024)
- AMICUS BRIEF (ATLANTIC LEGAL FOUNDATION) (Jul 16, 2024)
- AMICUS BRIEF (WASHINGTON LEGAL FOUNDATION) (Jul 15, 2024)
- BRIEF OF APPELLANT (Janssen) (Jul 12, 2024)
- ORDER (Jun 13, 2024)
- ORDER (May 23, 2024)
- MOTION TO EXPEDITE (May 15, 2024)
- ORDER (May 6, 2024)